Performance

Strategy

Leadership

Statements

Investing in Philips

How we make a difference

Annual Report 2010

My Annual Report
Start creating your
PDF below
Add this page
0 pages selected
Downloads

Five-year overview

All amounts in millions of euros unless otherwise stated. Due to factors such as acquisitions and divestments, the amounts, percentages and ratios are not directly comparable.

 
General data
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
Sales
26,682
26,793
26,385
23,189
25,419
Percentage increase over previous year
5
(2)
(12)
10
 
 
 
 
 
 
Income (loss) from continuing operations
1,003
5,018
(95)
424
1,452
Discontinued operations
4,154
(138)
3
Net income (loss)
5,157
4,880
(92)
424
1,452
 
 
 
 
 
 
Free cash flow
(348)
824
773
863
1,333
Turnover rate of net operating capital
3.73
2.71
1.72
1.79
1.91
Total employees at year-end (in thousands)
1224)
1244)
121
116
119
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
4) Including discontinued operations
5) In millions of shares
6) In manufacturing excluding new acquisitions
 
Income
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
EBIT
1,336
1,867
54
614
2,065
as a % of sales
5.0
7.0
0.2
2.6
8.1
 
 
 
 
 
 
EBITA
1,528
2,094
744
1,050
2,552
as a % of sales
5.7
7.8
2.8
4.5
10.0
 
 
 
 
 
 
Income taxes
(223)
(582)
(256)
(100)
(509)
as a % of income before taxes
(16.3)
(12.3)
(180.2)
(22.3)
(26.2)
 
 
 
 
 
 
Income (loss) from continuing operations
1,003
5,018
(95)
424
1,452
as a % of shareholders’ equity (ROE)
4.8
22.8
(0.5)
2.9
9.6
 
 
 
 
 
 
Net income (loss)
5,157
4,880
(92)
424
1,452
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
 
Capital employed
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
Cash and cash equivalents
5,886
8,769
3,620
4,386
5,833
Receivables and other current assets
5,502
5,292
5,038
4,610
4,899
Assets of discontinued operations
427
319
Inventories
2,940
3,213
3,491
2,913
3,865
Non-current financial assets/investments in associates
10,924
5,000
1,624
972
660
Non-current receivables/assets
3,905
3,959
2,884
2,871
1,514
Property, plant and equipment
3,102
3,194
3,496
3,252
3,265
Intangible assets
5,964
6,635
11,757
11,523
12,233
Total assets
38,650
36,381
31,910
30,527
32,269
 
 
 
 
 
 
Property, plant and equipment:
 
 
 
 
 
Capital expenditures for the year
698
658
770
524
653
Depreciation for the year
990
562
729
746
678
Capital expenditures : depreciation
0.7
1.2
1.1
0.7
1.0
 
 
 
 
 
 
Inventories as a % of sales
11.0
12.0
13.2
12.6
15.2
Outstanding trade receivables, in days sales
45
44
42
40
46
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
 
Financial structure
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
Other liabilities
8,837
8,469
9,292
9,166
10,180
Liabilities of discontinued operations
78
78
Debt
3,878
3,563
4,188
4,267
4,658
Provisions
2,623
2,403
2,837
2,450
2,339
Total provisions and liabilities
15,416
14,513
16,317
15,883
17,177
 
 
 
 
 
 
Shareholders’ equity
23,099
21,741
15,544
14,595
15,046
Non-controlling interests
135
127
49
49
46
 
 
 
 
 
 
Group equity and liabilities
38,650
36,381
31,910
30,527
32,269
 
 
 
 
 
 
Net debt : group equity ratio
(9):109
(31):131
4:96
(1):101
(8):108
 
 
 
 
 
 
Market capitalization at year-end
31,624
31,436
12,765
19,170
21,705
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
 
Key figures per share
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
Sales per common share
22.71
24.67
26.62
25.07
27.04
EBITA per common share - diluted
1.29
1.91
0.75
1.13
2.69
Income (loss) from continuing operations per share
0.85
4.61
(0.09)
0.46
1.54
Dividend distributed per common share
0.44
0.60
0.70
0.70
0.70
Total shareholder return per common share
2.76
1.55
(14.99)
7.55
2.94
Shareholders’ equity per common share
20.87
20.41
16.84
15.74
15.89
Price/earnings ratio
33.61
6.40
(153.67)
44.96
14.88
Share price at year-end
28.57
29.52
13.83
20.68
22.92
Highest closing share price during the year
29.31
32.99
28.94
21.03
26.94
Lowest closing share price during the year
21.89
26.71
12.09
10.95
20.34
Average share price
26.57
29.73
21.42
15.26
23.35
Common shares outstanding at year-end5)
1,107
1,065
923
927
947
Weighted average shares outstanding:
 
 
 
 
 
- basic5)
1,175
1,086
991
925
940
- diluted5)
1,184
1,099
997
929
948
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
4) Including discontinued operations
5) In millions of shares
 
Sustainability
20061,2,3)
20073)
2008
2009
2010
 
 
 
 
 
 
Lives touched, in millions
420
Energy efficiency of products, in kWh/EUR
10.5
10.1
Collection and recycling amount, in tons
100,000
Recycled material in products, in tons
7,500
Green Product sales, as a % of total sales
15.0
19.8
22.6
30.6
37.5
Green Innovation, in millions of euros
282
410
451
Operational carbon footprint, in kilotons CO2-equivalent
2,157
2,144
1,937
1,808
Operational energy efficiency, in terajoules per million euro sales
1.29
1.31
1.35
1.26
Total energy consumption in manufacturing, in terajoules6)
15,213
15,207
14,602
14,294
14,232
Total carbon emissions in manufacturing, in kilotons CO2-equivalent6)
869
864
823
816
668
Water intake, in thousands m3 6)
4,171
4,209
3,996
4,216
4,217
Total waste, in kilotons6)
125.4
127.6
113.6
97.7
104.5
Materials provided for recycling via external contractor per total waste, in %
79
79
76
77
78
Restricted substances, in kilos
2,097
1,367
1,098
638
1,036
Hazardous substances, in kilos
119,455
90,807
46,316
33,644
68,100
ISO 14001 certification, as a % of all reporting organizations6)
92
90
95
92
95
Employee Engagement Index, % favorable
61
64
69
68
75
Female executives, in % of total
6
8
10
10
11
Lost Workday Injuries, per 100 FTEs
0.78
0.81
0.68
0.44
0.50
Initial and continual conformance audits, number of audits
365
166
277
360
273
1) Discontinued operations reflects the effect of the sale of MDS in 2006
2) Discontinued operations reflects the effect of the sale of Semiconductors in 2006
3) Discontinued operations reflects the effect of classifying the MedQuist business as a discontinued operation in 2007, for which the previous year has been restated
4) Including discontinued operations
5) In millions of shares
6) In manufacturing excluding new acquisitions
Sustainability analyst
Financial analyst
Employee
...
debugging messages
This is an interactive electronic version of the Philips Annual Report 2010 and also contains certain information in summarized form. The contents of this version are qualified in their entirety by reference to the printed version of the full Philips Annual Report 2010. This printed version is available as a PDF file on this website. Information about: forward-looking statements, third-party market share data, fair value information, IFRS basis of presentation, use of non-GAAP information, statutory financial statements and management report, reclassifications and analysis of 2009 compared to 2008.

Free cash flow is the net cash flow from operating activities minus net capital expenditures.

Earnings before interest, tax and amortization (EBITA) represents income from continuing operations excluding results attributable to non-controlling interest holders, results relating to investments in associates, income taxes, financial income and expenses, amortization and impairment on intangible assets (excluding software and capitalized development expenses). Philips believes that EBITA information makes the underlying performance of its businesses more transparent by factoring out the amortization of these intangible assets, which arises when acquisitions are consolidated.

This ratio measures income from continuing operations as percentage of average shareholders’ equity. ROE rates Philips’ overall profitability by evaluating how much profit the company generates with the money shareholders have invested.

A carbon footprint is the total set of greenhouse gas emissions caused by an organization, event, product or person; usually expressed in kilotons CO2-equivalent. The Philips operational carbon footprint is calculated on a half-year basis and includes industrial sites (manufacturing and assembly sites), non-industrial sites (offices, warehouses, IT centers and R&D facilities), business travel (lease and rental cars, and airplane travel) and logistics (air, sea and road transport).